Table 3.
OR and CI for retinopathy according to baseline characteristics of study participants.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |
| Clinical | ||||||
| Sex | 1.25 | 0.96–1.63 | 0.098 | 1.34 | 0.99–1.84 | 0.063 |
| Age (per year) | 0.97 | 0.95–0.98 | < 0.001 | 0.97 | 0.95–0.99 | 0.001 |
| Age (per stratum) | 0.70 | 0.59–0.83 | < 0.001 | 0.70 | 0.59–0.83 | < 0.001 |
| BMI (per kg/m2) | 1.03 | 1.00–1.06 | 0.044 | 1.01 | 0.98–1.05 | 0.477 |
| Smoking | 0.69 | 0.46–1.04 | 0.079 | 0.56 | 0.35–0.90 | 0.018 |
| Time on dialysis (per month) | 1.04 | 1.02–1.07 | 0.001 | 1.04 | 1.01–1.06 | 0.004 |
| Macrovascular disease | ||||||
| MI | 0.79 | 0.56–1.10 | 0.156 | 1.29 | 0.62–2.70 | 0.498 |
| PTCA | 0.68 | 0.41–1.31 | 0.137 | 0.95 | 0.47–1.94 | 0.895 |
| CABG | 0.93 | 0.58–1.49 | 0.771 | 2.05 | 1.06–3.96 | 0.034 |
| Overall-CAD (MI or PTCA or CABG) | 0.68 | 0.51–0.92 | 0.013 | 0.69 | 0.50–0.96 | 0.026 |
| Stroke / TIA | 1.06 | 0.75–1.50 | 0.737 | 1.02 | 0.70–1.49 | 0.934 |
| Microvascular disease | ||||||
| PVD | 1.71 | 1.30–2.24 | < 0.001 | 1.24 | 0.89–1.71 | 0.203 |
| PN | 4.90 | 3.68–6.52 | < 0.001 | 3.61 | 2.66–4.89 | < 0.001 |
| DG | 2.63 | 1.68–4.12 | < 0.001 | 1.46 | 0.89–2.41 | 0.139 |
| NS | 2.03 | 1.48–2.79 | < 0.001 | 1.60 | 1.13–2.25 | 0.008 |
OR: odds ratio; CI: confidence interval, BMI: body mass index; MI: myocardial infarction; PTCA: percutaneous transluminal coronary angioplasty; CABG: coronary artery bypass graft; CAD: coronary artery disease; TIA: transitoric ischemic attack; CHD: coronary heart disease; PVD: peripheral vascular disease; PN: polyneuropathy; DG: diabetic gangrene; NS: nephrotic syndrome. The P-data which is shown bolded is statistically significant.